At a World Malaria Day event in Paris, four technology companies have announced they will contribute $4.3m in technical support to healthcare non-profit PATH’s Visualise No Malaria project. The companies...
25 April 2019 News
23 April 2019 News
The World Health Organization (WHO) has announced that the Government of Malawi has immunised the first children with RTS,S/AS01 (RTS,S), the world’s first malaria vaccine.
16 April 2019 Comment
On April 3, the US National Institutes of Health (NIH) announced the start of a Phase I clinical trial investigating the safety, tolerability, and immunogenicity of its universal influenza vaccine...
5 April 2019 News
Gilead has submitted a supplemental new drug application (sNDA) to the US Food and Drug Administration (FDA) for antiviral Descovy (emtricitabine and tenofovir alafenamide) for pre-exposure prophylaxis (PrEP) to reduce...
4 April 2019 News
The US National Institutes of Health (NIH) has announced it has enrolled patients into the first Phase I trial of an innovative, experimental universal vaccine candidate H1ssF_3928.
28 March 2019 News
Nationalised or state-run ‘utility’ type drug companies could be the best solution to address the lack of pharmaceutical industry’s action towards superbugs threat, said former UK government adviser Jim O’Neill.
27 March 2019 Comment
Although only a small proportion of people who are exposed will develop TB in their lifetime, the risk of contracting TB is higher among immunocompromised individuals.
26 March 2019 News
North American pharma company CytoDyn has announced that its primary product leronlimab exceeded expectations as a monotherapy for human immunodeficiency virus (HIV).